Know Cancer

or
forgot password

F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With AML


N/A
18 Years
N/A
Not Enrolling
Both
Acute Myeloid Leucemia

Thank you

Trial Information

F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With AML


Inclusion Criteria:



- new diagnosis of AML

Exclusion Criteria:

- pregnancy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Measure of extent and intensity ( by standardized uptake value - SUV) of disease in bone marrow demonstrated on PET/CT images before and after treatment.

Authority:

Israel: Ministry of Health

Study ID:

0112-12-HMO

NCT ID:

NCT01592266

Start Date:

October 2012

Completion Date:

Related Keywords:

  • Acute Myeloid Leucemia
  • FLT
  • PET
  • bone marrow
  • AML
  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid

Name

Location